Amgen reported early Phase 2 data suggesting patients kept weight off with less frequent dosing, a potential differentiator ...
Amneal Pharmaceuticals has just seen its fair value estimate nudged to US$14.00 from US$13.80, a small but meaningful reset that ties directly to how the latest quarterly numbers stack up against ...
Zacks.com on MSN
BMY vs AMGN: Which Biotech Stock Is More Resilient Now?
From a price-performance perspective, BMY has fetched slightly better returns than AMGN in the past six months. Shares of ...
Novo Nordisk carries a Zacks Rank #5 (Strong Sell), whereas Amgen carries a Zacks Rank #3 (Hold) at present, which makes AMGN ...
Biosimilar partnerships and EU approvals surge, enhancing access to innovative treatments in immunology, oncology, and bone health markets.
Denosumab is a monoclonal antibody that inhibits bone resorption and is widely used across oncology and osteoporosis-related ...
It depends. There have been a few clinical trials on the impact of GLP-1 injectable medications on weight loss with different ...
MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from ...
Bridgewater headquartered Amneal Pharmaceuticals Inc, a global biopharmaceutical company, and mAbxience, a Fresenius Kabi majority-owned group with partial ownership from Insud Pharma, announced that ...
Glucocorticoid injections into the infrapatellar fat pad do not reduce knee pain or effusion synovitis volume in patients ...
MADRID, Dec. 22, 2025 /PRNewswire/ -- mAbxience, a Fresenius Kabi majority-owned group with partial ownership from Insud Pharma, and Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") (NASDAQ: ...
When a person suffers a stroke, physicians must restore blood flow to the brain as quickly as possible to save their life.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback